Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.
about
Overcoming Resistance of Human Non-Hodgkin's Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@en
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@nl
type
label
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@en
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@nl
prefLabel
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@en
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@nl
P2860
P356
P1433
P1476
Overcoming Resistance of Human ...... istone Deacetylase Inhibitors.
@en
P2093
Ali R Jazirehi
P2860
P356
10.3390/CANCERS10060200
P577
2018-06-14T00:00:00Z